- $1.53bn
- $1.74bn
- $861.74m
- 93
- 45
- 38
- 60
2019 December 28th | 2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 509 | 659 | 787 | 707 | 862 |
Cost of Revenue | |||||
Gross Profit | 245 | 335 | 386 | 359 | 430 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 478 | 615 | 721 | 638 | 801 |
Operating Profit | 31.2 | 44.1 | 66.2 | 68.3 | 61.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 28.9 | 29 | 62.4 | 62.1 | 48.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.8 | 21 | 50 | 47.1 | 44.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 23.8 | 21 | 50 | 47.1 | 44.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.8 | 21 | 50 | 47.1 | 44.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.9 | 1.65 | 3.27 | 3.22 | 2.88 |